BCR and acute lymphoblastic leukemia: In the ALL sample PDX-ALL3 with hyperactive tyrosine kinase signaling (BCR::ABL1+) 12 μM PZ48 evoked 43% apoptosis (Fig. 1F; p ≤ 0.0001).